Unknown NA INTERVENTIONAL 1-arm NCT04451239

Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis

Combined Topical Corticosteroid and Topical Cyclosporine-A for Management of COVID-19 Keratoconjunctivitis; a Pilot Study

Sponsor: Ameera Gamal Abdelhameed

Conditions Keratonjunctivitis

Interventions topical steroids and cyclosporin-A

Updated 6 times since 2020 Last updated: Jun 28, 2020 Started: Jun 30, 2020 Primary completion: Jul 31, 2020 Completion: Jul 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Keratonjunctivitis, this trial is ongoing. The trial is conducted by Ameera Gamal Abdelhameed and has accumulated 6 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jul 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jul 2022 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jul 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ameera Gamal Abdelhameed
Ministry of Health, Kuwait

Data source: Mansoura University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kuwait City, Kuwait